These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34797597)

  • 1. Comparison of the efficacy and safety of intralesional injection of tranexamic acid and the topical application of Kligman combination drug in the treatment of macular amyloidosis.
    Ghassemi M; Roohaninasab M; Kamani SA; Sadeghzadeh-Bazargan A; Goodarzi A
    Dermatol Ther; 2022 Jan; 35(1):e15213. PubMed ID: 34797597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fractional CO
    Sobhi RM; Sharaoui I; El Nabarawy EA; El Nemr Esmail RS; Hegazy RA; Aref DHF
    Lasers Med Sci; 2018 May; 33(4):909-916. PubMed ID: 29480422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy alone and in combination with erbium:YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis.
    Nilforoushzadeh MA; Zolghadr S; Heidari-Kharaji M; Alavi S; Mahmoudbeyk M
    Lasers Med Sci; 2020 Jul; 35(5):1171-1177. PubMed ID: 31916020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial.
    Abtahi-Naeini B; Hemati E; Faghihi G; Shahmoradi Z; Paknazar F; Rastegarnasab F; Varshosaz J; Hadian M; Akbari M; Sabzghabaee AM
    J Cosmet Dermatol; 2024 May; 23(5):1677-1684. PubMed ID: 38291677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical resolution of generalized lichen amyloidosis with dupilumab: a new alternative therapy.
    Humeda Y; Beasley J; Calder K
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
    Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
    J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders.
    Verma P; Yadav KS
    Expert Opin Drug Deliv; 2023 Jun; 20(6):773-783. PubMed ID: 37086183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Efficacy of Intralesional Tranexamic Acid Versus Topical 4% Hydroquinone in Treating Melasma.
    Mushtaq S; Sibgha Naz S; Rizwan M; Jehangir Khan N; Ullah O; Muhammad A
    Cureus; 2022 Aug; 14(8):e28547. PubMed ID: 36185872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
    Tammachote N; Raphiphan R; Kanitnate S
    Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial.
    Lee DH; Oh IY; Koo KT; Suk JM; Jung SW; Park JO; Kim BJ; Choi YM
    Skin Res Technol; 2014 May; 20(2):208-12. PubMed ID: 24033822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular amyloidosis diagnostic outcomes of skin biopsy: A systematic review.
    Alhawas F; Obaid SB; Alfawzan O; Fathaddin A; Alsuwaidan S; Alajlan A
    J Cutan Pathol; 2024 May; 51(5):393-397. PubMed ID: 38328942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
    Lošťák J; Gallo J; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
    Desai S; Chan L; Handog E; Djojoseputro L; Lim J; Ling R; Nguyen H; Tam E; Tang J; Thng S; Tran H
    J Drugs Dermatol; 2023 Apr; 22(4):386-392. PubMed ID: 37026889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.